SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-14-058548
Filing Date
2014-08-08
Accepted
2014-08-08 07:45:05
Documents
6
Period of Report
2014-08-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a14-18606_28k.htm 8-K 36896
2 EX-10.1 a14-18606_2ex10d1.htm EX-10.1 49683
3 EX-10.2 a14-18606_2ex10d2.htm EX-10.2 70103
4 EX-10.3 a14-18606_2ex10d3.htm EX-10.3 69199
5 GRAPHIC g186062koi001.jpg GRAPHIC 4433
6 GRAPHIC g186062kki001.jpg GRAPHIC 3202
  Complete submission text file 0001104659-14-058548.txt   237879
Mailing Address 2 MERCER ROAD NATICK MA 01760
Business Address 2 MERCER ROAD NATICK MA 01760 508-975-4820
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36167 | Film No.: 141025606
SIC: 2834 Pharmaceutical Preparations